EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.14.99.1 | 11beta-hydroxysteroid dehydrogenase deficiency |
15718388 |
Interactions between 11beta-hydroxysteroid dehydrogenase and COX-2 in kidney. |
causal interaction ongoing research unassigned |
4 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
8601574 |
Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2. |
causal interaction therapeutic application unassigned |
3 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
8840961 |
Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. |
causal interaction ongoing research therapeutic application unassigned |
4 1 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
9439679 |
Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats. |
causal interaction ongoing research therapeutic application unassigned |
4 4 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
9458081 |
Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. |
causal interaction therapeutic application unassigned |
4 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
11216473 |
COX-2 and iNOS, good targets for chemoprevention of colon cancer. |
causal interaction ongoing research therapeutic application unassigned |
4 3 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
11280748 |
Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids. |
causal interaction diagnostic usage ongoing research therapeutic application |
4 3 3 1 |
1.14.99.1 | Aberrant Crypt Foci |
11782374 |
Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. |
causal interaction diagnostic usage therapeutic application unassigned |
4 3 4 0 |
1.14.99.1 | Aberrant Crypt Foci |
14583451 |
Energy restriction reduces the number of advanced aberrant crypt foci and attenuates the expression of colonic transforming growth factor beta and cyclooxygenase isoforms in Zucker obese (fa/fa) rats. |
causal interaction diagnostic usage ongoing research unassigned |
1 4 1 0 |
1.14.99.1 | Aberrant Crypt Foci |
14643021 |
Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis. |
causal interaction ongoing research therapeutic application unassigned |
4 2 4 0 |